Editorial
Increase in Covid-19 testing helping Dr Lal PathLabs
Discover how Dr Lal PathLabs, a leading diagnostic service provider, is experiencing increased business and investor interest due to the surge in Covid-19 testing in India.
Editorial · page 21
Editorial
Is Tejas Networks Really Your Multibagger Stock?
Explore Tejas Networks' financial performance, product portfolio, and stock trajectory. Is this telecom networking company a multibagger opportunity despite past inconsistencies?
Editorial
Intellect Design Arena - Company Analysis
Explore Intellect Design Arena's financial performance, revenue growth, and stock market journey. Learn about this Indian fintech company's services and market position.
Editorial
Why Are Gold Prices Falling After Touching A Record High last September?
Discover the reasons behind the recent fall in gold prices from their September 2020 record high, including investor risk appetite, dollar strength, and bond yields.
Editorial
Best Stocks to Watch in the Education and Training Sector
Explore top stocks in India's growing education and training sector, including Ed-Tech companies and traditional players like Zee Learn, Career Point, NIIT, and Aptech.
Editorial
Macrotech Developers IPO: Should You Invest?
Explore the Macrotech Developers IPO details, financial health, and market position. Learn about the risks and rewards before deciding to invest in this real estate giant.
Editorial
Godrej Consumer Products: An Analysis
Explore Godrej Consumer Products Limited (GCPL), a leading Indian FMCG firm. Learn about its profile, financial performance, and strategic market expansion plans.
Editorial
Vaccine Wars: Can India Come Out on Top?
Explore the global 'Vaccine Wars' as India, China, EU, and UK compete in vaccine production and diplomacy. Learn about India's COVAXIN and COVISHIELD, and its Vaccine MAITRI program.
Editorial
Why are Indian Pharma Companies Investing in ABCD Technologies?
Discover why major Indian pharma companies like Sun Pharma, Cadila, Lupin, and Torrent are investing in ABCD Technologies to acquire Pharmarack and compete in the growing e-pharma market against giants like Reliance and Amazon.
Editorial
What are New Umbrella Entities? Why are Tata to Reliance Interested in it?
Explore New Umbrella Entities (NUEs) in India, the RBI's vision for digital payments, and why major players like Tata, Reliance, and Amazon are keen to participate.
Editorial
The Collapse of Archegos Capital: Explained
Understand the collapse of Archegos Capital, a New York-based wealth management firm, and its impact on global stock markets and major banks.
Editorial
The Turkish Economy Is Facing A Neverending Crisis: Here's Why
Explore the ongoing crisis in the Turkish economy, the fall of the Lira, and the impact of President Erdogan's interest rate policies since 2016.